TY - JOUR
T1 - Conjugation of phenylboronic acid moiety through multistep organic transformations on nanodiamond surface for an anticancer nanodrug for boron neutron capture therapy
AU - Nishikawa, Masahiro
AU - Kang, Heon Gyu
AU - Zou, Yajuan
AU - Takeuchi, Hidekazu
AU - Matsuno, Naoyoshi
AU - Suzuki, Minoru
AU - Komatsu, Naoki
N1 - Publisher Copyright:
© 2021 The Chemical Society of Japan
PY - 2021
Y1 - 2021
N2 - Detonation nanodiamonds (DNDs) have attracted considerable attention, in particular, in the field of nanomedicine due to their biocompatibility as well as various functionalities imparted by surface modification. Meanwhile, boron neutron capture therapy (BNCT) is an advanced cancer treatment utilizing nuclear fission reaction of 10B upon neutron irradiation. Recently, quite a few boron-containing nanoparticles have been investigated to deliver 10B atoms into cancer tissue selectively and retentively. In this study, we explored boronic acid functionalized DNDs as an anticancer agent for BNCT. Phenylboronic acid (PBA) moiety was introduced to poly-glycerol (PG) modified DNDs (DND-PG) through multistep organic transformation, giving percent order of boron atoms. The process is scalable and reliable by simple covalent chemistry and the resulting product is well dispersed, and stable chemically and physically under physiological conditions. In the in vivo experiments, the resulting material was accumulated in the tumor to exert BNCT efficacy upon neutron irradiation. These results demonstrate that the PBA functionalized DNDs are a promising candidate as an anticancer nanodrug for BNCT.
AB - Detonation nanodiamonds (DNDs) have attracted considerable attention, in particular, in the field of nanomedicine due to their biocompatibility as well as various functionalities imparted by surface modification. Meanwhile, boron neutron capture therapy (BNCT) is an advanced cancer treatment utilizing nuclear fission reaction of 10B upon neutron irradiation. Recently, quite a few boron-containing nanoparticles have been investigated to deliver 10B atoms into cancer tissue selectively and retentively. In this study, we explored boronic acid functionalized DNDs as an anticancer agent for BNCT. Phenylboronic acid (PBA) moiety was introduced to poly-glycerol (PG) modified DNDs (DND-PG) through multistep organic transformation, giving percent order of boron atoms. The process is scalable and reliable by simple covalent chemistry and the resulting product is well dispersed, and stable chemically and physically under physiological conditions. In the in vivo experiments, the resulting material was accumulated in the tumor to exert BNCT efficacy upon neutron irradiation. These results demonstrate that the PBA functionalized DNDs are a promising candidate as an anticancer nanodrug for BNCT.
KW - Boron neutron capture therapy (BNCT)
KW - Nanodiamond
KW - Surface modification
UR - http://www.scopus.com/inward/record.url?scp=85117889692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117889692&partnerID=8YFLogxK
U2 - 10.1246/bcsj.20210200
DO - 10.1246/bcsj.20210200
M3 - Article
AN - SCOPUS:85117889692
SN - 0009-2673
VL - 94
SP - 2302
EP - 2312
JO - Bulletin of the Chemical Society of Japan
JF - Bulletin of the Chemical Society of Japan
IS - 9
ER -